Presentation is loading. Please wait.

Presentation is loading. Please wait.

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients  Christopher D.

Published byRuchi Chawla Modified over 5 years ago

Similar presentations

Presentation on theme: "Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients  Christopher D."— Presentation transcript:

1 Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients  Christopher D. Leville, MD, Vikram S. Kashyap, MD, Daniel G. Clair, MD, James F. Bena, MS, Sean P. Lyden, MD, Roy K. Greenberg, MD, Patrick J. O’Hara, MD, Timur P. Sarac, MD, Kenneth Ouriel, MD  Journal of Vascular Surgery  Volume 43, Issue 1, Pages (January 2006) DOI: /j.jvs Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

2 Fig 1 A, Transbrachial aortography documents a TransAtlantic Inter-Society Consensus class D iliac occlusion with right external iliac occlusion and complete occlusion of the left iliac system in a 46-year-old man with disabling claudication. B, Endovascular recanalization was performed with a hydrophilic guidewire and catheter, and femoral access was obtained with ultrasound guidance. Primary stenting with self-expanding nitinol stents with postdeployment balloon angioplasty restored normal pulsatile perfusion to both lower extremities, with palpable pedal pulses. Note that the right hypogastric circulation and other lumbar collateral arteries are preserved. Journal of Vascular Surgery  , 32-39DOI: ( /j.jvs ) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

3 Fig 2 Kaplan-Meier curve estimates for primary patency, secondary patency, and limb salvage in all patients treated for iliac occlusion over 36 months. Primary patency was 76%, secondary patency was 90%, and limb salvage was 97% at 36 months with an SE less than 10%. Journal of Vascular Surgery  , 32-39DOI: ( /j.jvs ) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

4 Fig 3 Kaplan-Meier curve estimates for primary patency in patients treated for iliac occlusion stratified by TransAtlantic Inter-Society Consensus (TASC) level over 36 months. No significant difference was found between groups. *SE exceeded 10%. Journal of Vascular Surgery  , 32-39DOI: ( /j.jvs ) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

5 Fig 4 Kaplan-Meier curve estimates for secondary patency in patients treated for iliac occlusion according to TransAtlantic Inter-Society Consensus (TASC) stratification. There was no significant difference between groups, and patency was greater than 90% for patients with type B and C iliac occlusions. *SE exceeded 10%. Journal of Vascular Surgery  , 32-39DOI: ( /j.jvs ) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

6 Fig 5 Kaplan-Meier primary patency curves for patients with diabetes (DM) as a variable. Patients with DM had a significantly lower patency when compared with nondiabetics (58% vs 83% at 36 months; P = .049). Journal of Vascular Surgery  , 32-39DOI: ( /j.jvs ) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Download ppt "Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients  Christopher D."

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.

Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Endovascular therapy for acute limb ischemia

Endovascular therapy for acute limb ischemia
Fenestrated endovascular grafting: The renal side of the story

Fenestrated endovascular grafting: The renal side of the story
Vikram S. Kashyap, MD, Ricardo N. Sepulveda, MD, James F

Vikram S. Kashyap, MD, Ricardo N. Sepulveda, MD, James F
Rafael D. Malgor, MD, Gustavo S. Oderich, MD, James C

Rafael D. Malgor, MD, Gustavo S. Oderich, MD, James C
Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion 

Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion 
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.
Vascular access in hemodialysis patients older than 80 years

Vascular access in hemodialysis patients older than 80 years
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Iliofemoral stenting for venous occlusive disease

Iliofemoral stenting for venous occlusive disease
Late graft explants in endovascular aneurysm repair

Late graft explants in endovascular aneurysm repair
Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypass 

Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypass 
Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage  Caren Randon, MD, Bart Jacobs, MD, Frederik.

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage  Caren Randon, MD, Bart Jacobs, MD, Frederik.

Similar presentations

Ads by Google